Data from the placebo group of the 4D study. This study aimed at comparing atorvastatin to placebo for patients with type 2 diabetes and receiving hemodialysis in terms of cariovascular events. The primary endpoint was a composite of death from cardiac causes, stroke and non-fatal myocardial infarction. Competing event was death from other causes.
data(fourD)A data frame with 636 observations on the following 7 variables.
idPatients' id number
sexPatients' gender
agePatients' age
medicationCharacter vector indicating treatment
affiliation. Here only equal to "Placebo"
statusStatus at the end of the follow-up. 1 for the event of interest, 2 for death from other causes and 0 for censored observations
timeSurvival time
treatedNumeric vector indicated whether patients are treated or not. Here always equal to zero
Allignol, A., Schumacher, M., Wanner, C., Dreschler, C. and Beyersmann, J. (2010). Understanding competing risks: a simulation point of view. Research report.